SCHEMBL29501431

SCHEMBL29501431

c1ccc2c(c1)CCN(C1CCCNCC1)C2

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.51
HTR2C P28335 4/20 0.50
HTR2B P41595 3/20 0.50
HRH3 Q9Y5N1 4/20 0.48
CYP2D6 P10635 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HTR2A P28223 1/20 0.43
CXCR3 P49682 1/20 0.43
MCOLN2 Q8IZK6 1/20 0.42
MCOLN3 Q8TDD5 1/20 0.42
MCOLN1 Q9GZU1 1/20 0.42
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22432705 1.00 SLC18A3 (0.51) SLC18A3HTR2CHTR2BHRH3CYP2D6
Hydrochloric Acid SCHEMBL30823789 0.98 SLC18A3 (0.50) SLC18A3HTR2CHTR2BHRH3CYP2D6
Hydrochloric Acid SCHEMBL22418694 0.98 SLC18A3 (0.50) SLC18A3HTR2CHTR2BHRH3CYP2D6
SCHEMBL29501341 0.94 SLC18A3 (0.53) SLC18A3HTR2CHTR2BHRH3SLC6A2
SCHEMBL2657988 0.94 SLC18A3 (0.53) SLC18A3HTR2CHTR2BHRH3SLC6A2
Hydrochloric Acid SCHEMBL29877056 0.92 SLC18A3 (0.51) SLC18A3HTR2CHTR2BHRH3SLC6A2
Hydrochloric Acid SCHEMBL5271851 0.92 SLC18A3 (0.51) SLC18A3HTR2CHTR2BHRH3SLC6A2
Hydrochloric Acid SCHEMBL16835555 0.92 SLC18A3 (0.51) SLC18A3HTR2CHTR2BHRH3SLC6A2
Bromide SCHEMBL6423364 0.92 SLC18A3 (0.51) SLC18A3HTR2CHTR2BHRH3SLC6A2
SCHEMBL6588816 0.88 SLC18A3 (0.51) SLC18A3HTR2CHTR2BSLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022048631-A1 COMPOUND HAVING ANTITUMOR ACTIVITY AND USE THEREOF 上海翊石医药科技有限公司 2022-03-10 WO disclosed